145 related articles for article (PubMed ID: 3091059)
1. Assessment of thrombogenicity of activated and non-activated prothrombin concentrates in a rat model.
Silberman S; Fareed J; Walenga J
Br J Exp Pathol; 1986 Aug; 67(4):597-604. PubMed ID: 3091059
[TBL] [Abstract][Full Text] [Related]
2. [Rodenticide effect of warfarin. 1. Effect on blood coagulation].
Niedner R; Kayser M; Meyer F
Arzneimittelforschung; 1974 May; 24(5):802-6. PubMed ID: 4408104
[No Abstract] [Full Text] [Related]
3. Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity.
MacGregor IR; Ferguson JM; McLaughlin LF; Burnouf T; Prowse CV
Thromb Haemost; 1991 Nov; 66(5):609-13. PubMed ID: 1803625
[TBL] [Abstract][Full Text] [Related]
4. Some effects of purified autoprothrombin C in blood clotting.
Müller-Berghaus G; Seegers WH
Thromb Diath Haemorrh; 1966 Dec; 16(3):707-22. PubMed ID: 5996683
[No Abstract] [Full Text] [Related]
5. Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation.
De Curtis A; D'Adamo MC; Amore C; Polishchuck R; Castelnuovo AD; Donati MB; Iacoviello L
Thromb Haemost; 2001 Dec; 86(6):1440-8. PubMed ID: 11776312
[TBL] [Abstract][Full Text] [Related]
6. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
Buchanan GR; Kevy SV
Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
Sultan Y; Loyer F
J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
[TBL] [Abstract][Full Text] [Related]
8. Problems of anticoagulation with warfarin in hyperthyroidism.
Kellett HA; Sawers JS; Boulton FE; Cholerton S; Park BK; Toft AD
Q J Med; 1986 Jan; 58(225):43-51. PubMed ID: 3704105
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
Mosterd JJ; Thijssen HH
J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
[TBL] [Abstract][Full Text] [Related]
10. Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats.
Vainieri H; Wingard LB
J Pharmacol Exp Ther; 1977 May; 201(2):507-17. PubMed ID: 870684
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced inhibitory effects of a prothrombin complex concentrate on global tests of haemostasis.
Takeyama M; Sakurai Y; Shima M; Matsumoto T; Nogami K; Tanaka I; Takeda T; Giddings JC; Yoshioka A
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):1-7. PubMed ID: 17179819
[TBL] [Abstract][Full Text] [Related]
12. Activated prothrombin concentrate for patients with factor VIII inhibitors.
Kurczynski EM; Penner JA
N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
[No Abstract] [Full Text] [Related]
13. A plasma factor enhances activity of vitamin K-dependent coagulation proteins.
Owens MR; Cimino CD
Thromb Haemost; 1983 Oct; 50(3):749-52. PubMed ID: 6648895
[TBL] [Abstract][Full Text] [Related]
14. Short term malathion ingestion and blood clotting in the rat.
Lox CD
J Environ Pathol Toxicol Oncol; 1985; 6(1):51-5. PubMed ID: 4067834
[TBL] [Abstract][Full Text] [Related]
15. The effects of coumadin on the prothrombin (factor II) coagulation pathway in man: relationship between antigen and activity levels.
Lox CD; Maciulla GJ; Heine MW; Messiha FS; Corrigan JJ
Proc West Pharmacol Soc; 1978; 21():237-9. PubMed ID: 693503
[No Abstract] [Full Text] [Related]
16. The effect of platelets on the in vitro response to prothrombin complex concentrates in F.VIII inhibitor plasma.
Castaldi PA; Smith IL
Pathology; 1980 Jan; 12(1):111-8. PubMed ID: 6769085
[TBL] [Abstract][Full Text] [Related]
17. Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.
Chan E; Aarons L; Serlin M; Breckenridge A; Rowland M
Br J Clin Pharmacol; 1987 Nov; 24(5):621-5. PubMed ID: 3435692
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
[TBL] [Abstract][Full Text] [Related]
19. [Thrombogenicity of a new prothrombin complex concentrate].
Klöcking HP; Klessen C; Jablonowski C; Meerbach W; Dornheim G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):645-61. PubMed ID: 6083940
[TBL] [Abstract][Full Text] [Related]
20. Warfarin therapy. 1.
Deykin D
N Engl J Med; 1970 Sep; 283(13):691-4. PubMed ID: 4916914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
